Alliance for Hippocratic Medicine v. Food and Drug Administration
Petition for certiorari denied on December 13, 2023
Issue: (1) Whether the Alliance's challenge to the Food and Drug Administration’s 2000 mifepristone approval is timely; and (2) whether FDA’s 2000 approval of mifepristone under 21 C.F.R. 314.500, which applies only to drugs that “treat[ ] serious or life-threatening illnesses,” and FDA’s subsequent approval of generic mifepristone were unlawful.
